799 – Efficacy of Upadacitinib As an Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis, with Or Without Previous Treatment Failure of Biologic Therapy: Data from the Dose-Ranging Phase 2B Study U-AchieveRemo Panaccione, Peter Higgins, Stefan Schreiber et al.|Gastroenterology|2019Cited by 11
678 Efficacy of Upadacitinib as an Induction Therapy in Severe and Refractory Ulcerative Colitis: Sub-Group Analysis of the Phase 2b Study U-ACHIEVEGeert D’Haens, Remo Panaccione, James O. Lindsay et al.|The American Journal of Gastroenterology|2019Cited by 0